Gaucher Disease NFZ — 32 facilities in 30 cities

Gaucher disease is a lysosomal storage disorder caused by glucocerebrosidase deficiency, leading to enlargement of the liver and spleen, anemia, thrombocytopenia, and bone damage. NFZ funds enzymatic diagnostics, genetic testing, and enzyme replacement therapy (imiglucerase, velaglucerase) or substrate reduction therapy through a dedicated drug program.